AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: schadenfreude who wrote (963)	11/20/1997 1:38:00 PM
From: D.Right	Read Replies (1) of 2173

Dear J Kniss: Well, I don't know how Barron calculated its figures. Let's just say the number is right. For $2-3 earnings, a P/E of 10 is $20-30, a P/E of 20 is $40-60 and a P/E of 30 is $60-90. The average P/E for most of the profit-generating biotech companies is very high because the patent deos protect the monopoly for many years (I have to check the exact years) from the day the drug is marketed. Good Day D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next